IsoRay, Inc. (NYSEAMERICAN: ISR) had an incredibly strong day in the market yesterday, closing the day with more than 100% gains on news of FDA clearance. However, today, the stock is falling, giving back a good chunk of those gains. So, what’s happening? Today, we’ll talk about: The FDA clearance; why the stock is falling … Read more
IsoRay, Inc. (NYSEAMERICAN: ISR) is a stock that we’ve followed for some time now, and every time we look into it, it seems to be more and more impressive. Recently, we decided to dig into the most recent quarterly report and other news that has been released. Here’s what we found… ISR Quarterly Results Highlights … Read more
IsoRay, Inc. (NYSEAMERICAN: ISR) is having an incredibly strong start to the trading session this morning after announcing the release of a new product. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about: The Build-Blu™ system; what we’re seeing from ISR as a result; and … Read more
IsoRay, Inc. (NYSEAMERICAN: ISR) is having an overwhelmingly strong day in the market today, and for good reason. The company announced that it has entered into a manufacturing and supply agreement surrounding Cesium-131. Today, we’ll talk about the agreement, what we’re seeing from the stock, and what we’ll be watching for ahead. ISR Enters Manufacturing … Read more
IsoRay, Inc. (NYSEMKT: ISR) I’ve been following IsoRay for quite some time now. Ever since I heard about Cesium-131, I’ve been interested in the company. While the stock hasn’t performed well over the past year, I believe that current data coming out with regard to the Cesium-131 treatment may change that in a big way. … Read more
IsoRay, Inc. (NYSEMKT: ISR) IsoRay is having an incredible day in the market after publishing a recent peer-reviewed Cesium-131 study result. Today, we’ll talk about the results of the recent study, how the market is reacting to the news, and what we can expect to see from ISR moving forward. ISR Publishes Positive Data In … Read more
IsoRay, Inc. (NASDAQ: ISR) IsoRay is having an incredible day in the market as a follow up to the great week we saw last week. Now the question is, “Is ISR finally seeing the growth it deserves?” Well, of course that’s my opinion, but I do believe that IsoRay deserves to see strong growth. With … Read more
If you follow my writing here or elsewhere, you know that my favorite sector to follow is biotech. With that said, I was digging around the biotech space earlier today and found a few stocks that are well worth keeping an eye on. Here’s what I was able to dig up… MannKind Corporation Stock Is … Read more
IsoRay, Inc. (NASDAQ: ISR) IsoRay, has had an interesting week in the market thus far. After announcing that Cesium-131 was indeed effective in the treatment of cancer, the company went under attack by Adam Feuerstein; who discredited their press release and drove the stock price down. However, I’ve said a few times since then that … Read more
Hey everyone, sorry for the short break in posts this morning. Just after posting this morning’s article on MannKind, I got a call from one of our amazing readers by the name of Russel to talk about MNKD, Afrezza, and more. While the conversation first started with MannKind, we ended up talking about how many … Read more